First-line disease modifying treatments in pediatric-onset multiple sclerosis in Greece: therapy initiation at more advanced age is the main cause of treatment failure, in a retrospective observational study, with a cohort from a single Multiple Sclerosis Center

OBJECTIVES: Long-term immunomodulatory therapy of pediatric onset-multiple sclerosis (POMS) is based mainly on published case series and internationally agreed guidelines. Relevant studies in the Greek population are absent from the literature. The purpose of this study is to present data on the eff...

Descripción completa

Detalles Bibliográficos
Autores principales: Skarlis, Charalampos, Markoglou, Nikolaos, Gontika, Maria, Bougea, Anastasia, Katsavos, Serafeim, Artemiadis, Artemios, Chrousos, George, Dalakas, Marinos, Stefanis, Leonidas, Anagnostouli, Maria
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer International Publishing 2022
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9842569/
https://www.ncbi.nlm.nih.gov/pubmed/36197577
http://dx.doi.org/10.1007/s10072-022-06431-y

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9842569/
https://www.ncbi.nlm.nih.gov/pubmed/36197577
http://dx.doi.org/10.1007/s10072-022-06431-y

Ejemplares similares